| Description |
1 online resource |
| Contents |
Pro-angiogenesis Targets and Clinical Implications -- Survey of Pro-angiogenesis Strategies / Shaker A. Mousa -- Angiogenesis Modulation by Arachidonic Acid-derived Lipids: Positive and Negative Regulators of Angiogenesis / Robert C. Block [and others] -- Pro-angiogenic Activity of Thyroid Hormone Analogues: Mechanisms, Physiology and Clinical Prospects / Paul J. Davis [and others] -- Actions of Steroids and Peptide Hormones on Angiogenesis / Paul J. Davis [and others] -- Role of Non-neuronal Nicotinic Acetylcholine Receptors in Angiogenesis Modulation / Shaker A. Mousa, Hugo R. Arias, Paul J. Davis -- Catecholamine Neurotransmitters: An Angiogenic Switch in the Tumor Microenvironment / Sujit Basu, Partha Sarathi Dasgupta -- Impact of Nanotechnology on Therapeutic Angiogenesis / Dhruba J. Bharali, Shaker A. Mousa -- Anti-angiogenesis Targets and Clinical Applications -- Survey of Anti-angiogenesis Strategies / Shaker A. Mousa -- Tetraiodothyroacetic Acid (Tetrac), Nanotetrac and Anti-angiogenesis / Paul J. Davis [and others] -- Integrin Antagonists and Angiogenesis / Shaker A. Mousa, Paul J. Davis -- Anti-angiogenesis Therapy as an Adjunct to Chemotherapy in Oncology / Shaker A. Mousa, Laila H. Anwar -- Anti-VEGF Strategies in Ocular Angiogenesis-mediated Disorders, with Special Emphasis on Age-related Macular Degeneration / Shaker A. Mousa -- Application of Nanotechnology to Prevent Tumor Angiogenesis for Therapeutic Benefit / Dhruba J. Bharali, Shaker A. Mousa -- Biomarkers of Response and Resistance to Anti-angiogenic Treatment / Dan G. Duda -- Speculations on New Directions in Which Angiogenesis May Proceed / Shaker A. Mousa, Paul J. Davis |
| Summary |
This book is a major update of novel targets in angiogenesis modulation, including pro- and anti-angiogenesis. There is in-depth coverage of preclinical and clinical methods and models, investigational status, and clinical applications. The impact of nanotechnology in advancing the applications of pro-and anti-angiogenesis strategies is also highlighted, along with stem cell and biotechnologies in research and development of angiogenesis modulating targets |
| Analysis |
Medicine |
|
Neurosciences |
|
Biotechnology |
|
Life sciences |
|
Cytology |
|
Biomedicine |
|
farmacie |
|
pharmacy |
|
levenswetenschappen |
|
celbiologie |
|
cellular biology |
|
biotechnologie |
|
biomedische wetenschappen |
|
neurowetenschap |
|
neuroscience |
|
Medicine (General) |
|
Geneeskunde (algemeen) |
| Notes |
Includes index |
| Bibliography |
Includes bibliographical references and index |
| Subject |
Neovascularization.
|
|
Neovascularization inhibitors.
|
|
Vascular endothelial growth factors.
|
|
Angiogenesis Inducing Agents
|
|
Angiogenesis Inhibitors
|
|
Neovascularization, Pathologic
|
|
MEDICAL -- Physiology.
|
|
SCIENCE -- Life Sciences -- Human Anatomy & Physiology.
|
|
Vascular endothelial growth factors
|
|
Neovascularization
|
|
Neovascularization inhibitors
|
| Form |
Electronic book
|
| Author |
Mousa, Shaker A
|
|
Davis, Paul J
|
| ISBN |
9789400764675 |
|
9400764677 |
|
